Pro Bono Perspectives S2E14: Lacy Caruthers, Google.org

Google.org Director of Global Employee Programs Lacy Caruthers joins host Danielle Holly to share how her organization is leveraging funding, technology, products and expertise to support racial justice organizations and provide COVID-19 relief.

It's Time to Re-think your CSR Portfolio

Executing citizenship programming comes with a very distinct tension – that employees and people leaders feel they have to choose: achieve the bottom line or create social impact. It doesn’t have to be a choice. Read the full blog here.

Understanding Your Impacts During COVID-19

What is COVID-19 teaching us about the need for organizations to show greater accountability and transparency?

Webcasts Focus on Role of Buildings, Communities and Organizations to Respond to Today's Global Health Challenges

With the gravity of the situation regarding COVID-19, today, more than ever, places matter to the future of protecting our families, our businesses and the public at large.

Global Citizen and the European Commission Announce Global Goal: Unite for Our Future - the Concert Hosted by Dwayne Johnson on June 27

Global Broadcast Special to Combat the Disproportionate Impact of COVID-19 on Marginalized Communities

New Bacardi Limited Website Gives Inside Look at Unique Culture

A revamped Corporate Responsibility (CR) section highlights goals and programs tied to each of the five Good Spirited pillars: Marketplace, People, Environment, Responsible Sourcing, and Philanthropy & Community Investment.

How a Father and His Teenage Daughter Bonded Over a Motorcycle Retrofit

Over the course of a month, Gwen and John Jessup completely revamped a 1982 Harley-Davidson together — and received a coveted award in recognition of their efforts.

An Open Letter from Daniel O'Day, Chairman & CEO, Gilead Sciences

After receiving the green light from the FDA to move forward, Gilead is about to start trials of an inhaled version of remdesivir. We will screen healthy volunteers for Phase 1 trials this week and hope to begin studies in patients with COVID-19...